Nurse Practitioner in Boyds, MD Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Beatrice Nyokabi Njoroge, NP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 22880 Whelan Ln, Boyds, MD 20841 Phone: 240-328-4588 |
Bridget Foretia Meyers, Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 18420 Clear Smoke Rd, Boyds, MD 20841 Phone: 301-237-3545 |
Martha Tadesse Chonchoro, PMHNP-BC Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 18842 Broken Oak Rd, Boyds, MD 20841 Phone: 301-222-7604 |
Dr. Jaimie Pollock, Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 12204 Greenridge Dr, Boyds, MD 20841 Phone: 609-970-5942 |
News Archive
SUNY Downstate signs new three-year agreement with Aetna
Aetna and the State University of New York (SUNY) Downstate Medical Center announced a new agreement for SUNY Downstate's resumed participation in the Aetna network, and the continuing participation of University Hospital of Brooklyn's recently acquired Long Island College Hospital campus.
Seven-year quest to understand how breast cancer cells resist treatment
A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that regulates cell death.
Unique approach to academia-industry training could help improve proton therapy treatment
Improving proton therapy for cancer treatment is one of the many advances in accelerator science that have been fast-tracked by a unique approach to academia-industry training, led by the Cockcroft Institute. The two programmes, which have produced 42 highly valued research fellows, are drawing to a conclusion and industry partners are warning of a skills chasm in the very near future unless further training is prioritised.
New procedure for transapical valve replacement minimizes trauma and blood loss
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
› Verified 7 days ago